Penthrox approved in Portugal and Switzerland
25 June 2018
ASX Announcement
Penthrox approved in Portugal and Switzerland.
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Switzerland and Portugal.
MVP CEO, Mr. John Sharman said, ?The roll out of Penthrox across Europe continues. We are delighted to have received the approval from Switzerland which is not part of the EU and therefore conducted its own independent assessment of Penthrox. We expect sales to commence in these markets during FY19.?
Refer to the following link for the full announcement – Penthrox approved in Switzerland and Portugal